Wellgistics Q1 revenue $0.93M, net loss $7.7M; terminates Neuritek/WellCare LOIs; guides Q2 ~$1.78M

Wellgistics Health, Inc.

2026-Q1 EPS reported -$0.07 revenue$1,559,563

Revenue $0.93M in Q1 2026 vs $0.49M Q4 2025; expects Q2 rev $1.78M (with $0.86M recognized through May 18).
Net operating loss $7.74M vs $32.43M prior year; EPS -$0.07 vs -$0.62 on 104.6M shares.
Wellgistics Pharmacy monthly rev grew from ~$0.1M (Nov 2025) to ~$0.6M (Apr 2026).
Terminated non-binding LOIs with Neuritek and WellCare; advanced discussions with Datavault AI for HaaS expansion.
Partnership with Tollo Health and NFL Alumni Health; Health Lives Here app launch targeted Aug 2026.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.